4.33
Lifemd Inc stock is traded at $4.33, with a volume of 811.64K.
It is down -2.70% in the last 24 hours and up +13.05% over the past month.
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.
See More
Previous Close:
$4.45
Open:
$4.38
24h Volume:
811.64K
Relative Volume:
0.67
Market Cap:
$209.41M
Revenue:
$234.96M
Net Income/Loss:
$-4.30M
P/E Ratio:
-21.78
EPS:
-0.1988
Net Cash Flow:
$-1.24M
1W Performance:
-9.41%
1M Performance:
+13.05%
6M Performance:
-6.48%
1Y Performance:
-55.22%
Lifemd Inc Stock (LFMD) Company Profile
Name
Lifemd Inc
Sector
Industry
Phone
(866) 351-5907
Address
236 FIFTH AVENUE, NEW YORK
Compare LFMD vs VEEV, BTSG, TEM, HQY, HNGE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
LFMD
Lifemd Inc
|
4.33 | 215.21M | 234.96M | -4.30M | -1.24M | -0.1988 |
|
VEEV
Veeva Systems Inc
|
158.86 | 25.50B | 3.20B | 908.91M | 1.39B | 5.4168 |
|
BTSG
Brightspring Health Services Inc
|
57.90 | 11.32B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TEM
Tempus Ai Inc
|
43.93 | 8.17B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
HQY
Healthequity Inc
|
82.17 | 6.90B | 1.31B | 215.20M | 408.32M | 2.4627 |
|
HNGE
Hinge Health Inc
|
54.50 | 4.17B | 587.86M | -425.10M | 0 | -5.691 |
Lifemd Inc Stock (LFMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-16-26 | Upgrade | Mizuho | Neutral → Outperform |
| Jun-18-25 | Reiterated | BTIG Research | Buy |
| Dec-10-24 | Initiated | Lake Street | Buy |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Aug-23-24 | Resumed | B. Riley Securities | Buy |
| Jun-05-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Nov-30-23 | Initiated | Craig Hallum | Buy |
| Jul-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-03-23 | Initiated | H.C. Wainwright | Buy |
| Mar-10-22 | Initiated | Colliers Securities | Buy |
| Oct-04-21 | Resumed | B. Riley Securities | Buy |
View All
Lifemd Inc Stock (LFMD) Latest News
LifeMD to Participate in Upcoming Investor Conferences - GlobeNewswire
LFMDP Technical Analysis | Trend, Signals & Chart Patterns | LIFEMD INCLFMD 8 7/8 PERP (NASDAQ:LFMDP) - ChartMill
LifeMD (LFMD) awards 337,500 restricted stock units to CFO Kavthekar - Stock Titan
LFMD Technical Analysis | Trend, Signals & Chart Patterns | LIFEMD INC (NASDAQ:LFMD) - ChartMill
LifeMD, Inc. (LFMD) Stock Analysis: A Telehealth Contender with a Promising 119.93% Upside - DirectorsTalk Interviews
LifeMD Earnings Call: Growth Surges, Profits Deferred - TipRanks
Why LifeStance Health Group Zoomed 20% Higher Today - AOL.com
LifeMD Posts Q1 Results, Reaffirms 2026 Profitability Outlook - The Globe and Mail
symbol__ Stock Quote Price and Forecast - CNN
Lake Street Maintains LifeMD(LFMD.US) With Buy Rating, Maintains Target Price $8 - Moomoo
Q1 2026 LifeMD Inc Earnings Call Transcript - GuruFocus
LifeMD, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
LifeMD, Inc. Q1 2026 Financial Report: SEC Filing, Company Details, and Financial Statements - Minichart
LifeMD Q1 2026 slides: AI-driven care platform beats estimates By Investing.com - Investing.com Australia
LifeMD Q1 2026 Earnings Call Transcript - MarketBeat
LifeMD Reports Q1 2026 Results: Record Subscriber Growth, 88% Gross Margin, and Strong Women’s Health Momentum - Minichart
LifeMD, Inc. (LFMD) reports Q1 loss, tops revenue estimates - MSN
LifeMD, Inc. (NASDAQ:LFMD) Q1 2026 Earnings Call Transcript - Insider Monkey
LifeMD (LFMD) Q1 2026 Earnings Transcript - AOL.com
LifeMD's Growth Gamble: Can Big Spending Fuel Telehealth Dominance? - BriefGlance
LifeMD Q1 Earnings Call Highlights - MarketBeat
LifeMD (NASDAQ:LFMD) Posts Quarterly Earnings Results, Misses Estimates By $0.06 EPS - MarketBeat
LifeMD (NASDAQ:LFMD) Q1 Beats Fails to Halt 13% After-Market Slide - ChartMill
LifeMD Q1 2026 slides: AI-driven care platform beats estimates - Investing.com
LifeMD, Inc. (LFMD) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Earnings call transcript: LifeMD Q1 2026 beats EPS and revenue forecasts - Investing.com Nigeria
LifeMD, Inc. 1Q 2026: Revenue $50.16M, EPS $(0.20) — 10-Q Summary - TradingView
[10-Q] LifeMD, Inc. Quarterly Earnings Report - Stock Titan
[8-K] LifeMD, Inc. Reports Material Event - Stock Titan
LifeMD adds 42,000 subscribers; women’s sign-ups jump 657% - Stock Titan
LifeMD Reports First Quarter 2026 Results - marketscreener.com
LifeMD, Inc. (NASDAQ:LFMD) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Hims & Hers Expands DTC Platform to Broaden Access to Personal Care - Yahoo Finance
LFMD.O - Reuters
LifeMD Inc expected to post a loss of 22 cents a shareEarnings Preview - TradingView
BTIG Maintains LifeMD(LFMD.US) With Buy Rating, Maintains Target Price $10 - Moomoo
LFMD Reiterated by BTIG -- Price Target Maintained at $10.00 - GuruFocus
LifeMD's (LFMD) Buy Rating Reiterated at BTIG Research - MarketBeat
How The LifeMD (LFMD) Story Is Shifting Around GLP-1 Growth And 2026 Expectations - Yahoo Finance
LIFEMD INC PFD SER A 8.875% (LFMDP.US) will release its earnings report after the market closes on May 6. - Moomoo
Earnings Preview: LifeMD to Report Financial Results Post-market on May 06 - Moomoo
Board revises equity incentives, enforces clawback in LifeMD (NASDAQ: LFMD) proxy - Stock Titan
LifeMD (LFMD) soars 23.7%: Is further upside left in the stock? - MSN
LFMD Technical Analysis & Stock Price Forecast - Intellectia AI
LifeMD (LFMD) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
LifeMD to Report First Quarter 2026 Financial Results on May 6 - The Manila Times
LifeMD, Inc. (LFMD) Reports Q2 Loss, Lags Revenue Estimates - MSN
LFMD (LifeMD Inc.) shares rise nearly four percent after Q4 2025 earnings narrowly miss analyst consensus estimates. - Cổng thông tin điện tử Tỉnh Sơn La
Lifemd Inc Stock (LFMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Lifemd Inc Stock (LFMD) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| FRIEDEMAN JESSICA | Chief Marketing Officer |
Dec 09 '25 |
Sale |
3.61 |
15,000 |
54,158 |
205,000 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):